Part Details | USP PENTAZOCINE LACTATE INJECTION
6505-00-689-5513
Alternate Parts: NDC00074192010, NDC00074-1920-10, NDC00074192010, NDC00074-1920-10, TALWIN INJECTION, TALWIN, NDC00024191601, NDC00024-1916-01, 6505-00-689-5513, 00-689-5513, 6505006895513, 006895513
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | FEB 07, 1968 | 00-689-5513 | 34147 ( PENTAZOCINE LACTATE INJECTION, USP ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-00-689-5513
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC00074-1920-10 | 23281 | ABBOTT LABORATORIES INCROSS PRODUCTS DIV |
| NDC00074-1920-10 | 70048 | ABBOTT LABORATORIESPHARMACEUTICAL PRODUCTS DIV |
| TALWIN INJECTION | 87811 | STERLING-WINTHROP RESEARCH INSTITUTEA DIV OF STERLING DRUG INC |
| TALWIN | 87811 | STERLING-WINTHROP RESEARCH INSTITUTEA DIV OF STERLING DRUG INC |
| NDC00024-1916-01 | 87811 | STERLING-WINTHROP RESEARCH INSTITUTEA DIV OF STERLING DRUG INC |
Technical Data | NSN 6505-00-689-5513
| Characteristic | Specifications |
|---|---|
| PRIMARY CONTAINER TYPE | BOTTLE |
| PRIMARY CONTAINER CONTENT QUANTITY | 10.000 MILLILITERS |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | BY30.000 MILLIGRAMS PENTAZOCINE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | PENTAZOCINE LACTATE INJECTION USP 30MG/ML 10ML VIAL |
| CONTROLLED SUBSTANCE CLASSIFICATION | SCHEDULE IV |